The news is directly related to UnitedHealth Group as Deutsche Bank has maintained a 'Buy' rating on the company but lowered the price target. This could potentially impact the stock's performance in the short term as investors adjust their expectations based on the new price target. However, the 'Buy' rating suggests that the bank still sees potential in the stock, which could balance out any negative impact from the lowered price target.